Journals / Endokrinolojide Diyalog Dergisi / 2013 / Cilt: 10 - Sayı: 2

Approach to obesity treatment in patients with diabetes mellitus

Diyabetlide obezite tedavisine yaklaşım

Pages
82–85
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

ÇOLAK, N. (2022). Approach to obesity treatment in patients with diabetes mellitus. Endokrinolojide Diyalog Dergisi, Cilt: 10 - Sayı: 2, 82–85. https://ajindex.com/articles/500710

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Akazawa S, Sun F, Ito M, Kawasaki E, Eguchi K. Efficacy of troglitazone on body fat distribution in type 2 diabetes. Diabetes Care 2000;23(8):1067-71
  2. Albrecht RJ, Pories WJ. Surgical intervention for the severely obese. Baillieres Best Pract Res Clin Endocrinol Metab 1999;13(1):149-72
  3. Astrup A. Dietary approach to reducing body weight. Baillieres Best Pract Res Clin Endocrinol Metab 1999;13(1):109-20
  4. Astrup A, Finer N. Redefining type 2 diabetes: “diabesity” or “obesity-dependent diabetes mellitus”? Obes Rev 2000;1(2):57-9
  5. Ballor DL, Poehlman EP, Toth MJ. Exercise as a treatment for obesity. “Handbook of Obesity, eds: GA Bray, C Bouchard, WPT James, Marcel Decker, New York, 1998” kitabından. Sayfa: 891-910
  6. Campbell L, Rössner S. Management of obesity in patients with Type 2 diabetes. Diabet Med 2001;18(5):345-54
  7. Chiasson JL, Josse RG, Gomis R, et al. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 2003;290(4):486-94
  8. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329(14):977-86
  9. Finer N, Bloom SR, Frost GS, Banks LM, Griffiths J. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study. Diabetes Obes Metab 2000;2(2):105-12
  10. Hollander PA, Elbein SC, Hirsch IB, et al. Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care. 1998;21(8):1288- 94
  11. Lean ME, Powrie JK, Anderson AS, Garthwaite PH. Obesity, weight loss and prognosis in type 2 diabetes. Diabet Med 1990;7(3):228-33
  12. Lee M, Aronne LJ. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction. Am J Cardiol 2007;99(4A):68B-79B. Epub 2006 Dec 27
  13. Lundgren H, Bengtsson C, Blohme G, Lapidus L, Sjöström L. Adiposity and adipose tissue distribution in relation to incidence of diabetes in women: results from a population study in Gothenburg, Sweden. Int J Obes 1989;13(4):413-23
  14. Markovic TP, Jenkins AB, Campbell LV, Furler SM, Kraegen EW, Chisholm DJ. The determinants of glycaemic responses to diet restriction and weight loss in obesity and NIDDM. Diabetes Care 1998;21(5):687-94
  15. Obesity. Prev